|Free Dividend Report|
|Stock Splits Calendar|
|AAVL Historical Stock Prices|
|Preferred Stock Newsletter|
|AAVL Options Chain|
|Stock Message Boards|
AAVL (AAVL) has the following price history information. Looking back at AAVL historical stock prices for the last five trading days, on May 05, 2016, AAVL opened at $5.05, traded as high as $5.26 and as low as $4.75, and closed at $4.83. Trading volume was a total of 326.60K shares. On May 06, 2016, AAVL opened at $4.70, traded as high as $4.83 and as low as $4.10, and closed at $4.14. Trading volume was a total of 542.10K shares. On May 09, 2016, AAVL opened at $4.15, traded as high as $4.15 and as low as $3.89, and closed at $4.03. Trading volume was a total of 374.90K shares. On May 10, 2016, AAVL opened at $4.08, traded as high as $4.40 and as low as $3.95, and closed at $4.32. Trading volume was a total of 220.50K shares. On May 11, 2016, AAVL opened at $4.30, traded as high as $4.30 and as low as $4.13, and closed at $4.14. Trading volume was a total of 281.60K shares.
AAVL Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AAVL shares, starting with a $10,000 purchase of AAVL, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||-63.76%|
|AAVL Historical Price Range|
|Avalanche Biotechnologies is a clinical-stage biotechnology company focused on discovering and developing gene therapies to treat patients with sight-threatening ophthalmic diseases. Co.'s main product candidate is AVA-101 for the treatment of wet age-related macular degeneration (AMD). AVA-101 enables retinal cells to continuously produce therapeutic levels of a naturally occurring anti-vascular endothelial growth factor protein with a single administration. In addition, Co.'s Ocular BioFactory platform has developed AVA-201, a product candidate for the prevention of wet AMD; and AVA-311, which is being evaluated in preclinical studies for the treatment of juvenile X-linked retinoschisis.|
|AAVL Historical Closing Prices|
|Healthcare Historical Prices|
|AAVL is categorized under the Healthcare sector; below are some other companies in the same sector:
ABAX Historical Stock Prices
AAVL Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2023, All Rights ReservedNothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.